Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This combination is a multi-ingredient antioxidant and neuroprotective formulation primarily used to manage peripheral neuropathies, particularly diabetic neuropathy. Alpha-lipoic acid (ALA) acts as a potent fat- and water-soluble antioxidant that regenerates other antioxidants like vitamins C and E while serving as a cofactor for mitochondrial energy metabolism. The B-complex vitamins (typically including B1, B2, B5, B6, and B12) support nerve cell function and myelin sheath maintenance. Together, these components work synergistically to reduce oxidative stress, improve nerve conduction velocity, and alleviate symptoms such as numbness, tingling, and pain associated with nerve damage.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on alpha lipoic acid + B vitamins + vitamin E + vitamin C.